期刊
NUTRIENTS
卷 14, 期 7, 页码 -出版社
MDPI
DOI: 10.3390/nu14071341
关键词
cystic fibrosis; pancreatic insufficiency; PERT; pancreatic enzymes; nutrition
Cystic fibrosis patients experience significant nutritional complications and comorbidities, especially those with pancreatic insufficiency. Prompt initiation of pancreatic enzymatic replacement therapy (PERT) is crucial and involves considerations such as administration methods, therapy failures, and complications.
While typically considered a pulmonary disease, cystic fibrosis patients develop significant nutritional complications and comorbidities, especially those who are pancreatic insufficient. Clinicians must have a high suspicion for cystic fibrosis among patients with clinical symptoms of pancreatic insufficiency, and pancreatic enzymatic replacement therapy (PERT) must be urgently initiated. PERT presents a myriad of considerations for patients and their supporting dieticians and clinicians, including types of administration, therapy failures, and complications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据